– Continued expansion of medical digital marketing solutions and online healthcare platforms
– Capture growth opportunities and create greater value

HONG KONG, Sept. 23, 2022 — (ACN Newswire) — China’s Leading Provider of Digital Health Service Solutions – Mediwelcome Healthcare Management & Technology Inc. (“Mediwelcome” or the “Company” and its Subsidiaries Together, the “Group”) ) (Securities Code: 2159) has announced its unaudited consolidated interim results for the six months ended June 30, 2022 (“Reporting Period” or “First Half of 2022”).

In the first half of 2022, Mediwelcome experienced contraction in revenue and other aspects to varying degrees due to continued lockdowns in many provinces in response to the severe pandemic in China. In the first half of 2022, Mediwelcome’s revenue decreased by about 49.2% to about RMB 172.5 million year-on-year. Gross profit was around RMB17.3 million. During the reporting period, the Group’s main revenues were generated from medical conference services, marketing strategy and consulting services, patient education and screening services, among others.

Continuously expanding medical digital marketing solutions and online healthcare platform, striving for digital upgrade

Although the economic environment faces great challenges under the epidemic situation, Mediwelcome always insists on continuously expanding and integrating integrated healthcare marketing solutions, developing an online healthcare platform and expanding business We are working together to fully implement the digital upgrade of During the reporting period, the medical conferencing service was the main revenue source, recording a revenue of approximately RMB 111.3 million, accounting for 64.5% of the total revenue. To enhance the group’s meeting management capabilities, Mediwelcome launched the Conference+ app for medical NGOs and pharmaceutical companies to submit onsite meeting requests and monitor meeting conduct. In terms of marketing strategy and consulting services, the Group assisted pharmaceutical companies in formulating and implementing effective business strategies to increase awareness of physician brands and products through this service. During the reporting period, marketing strategy and consulting services recorded revenue of approximately RMB 41.3 million, accounting for 23.9% of total revenue. Revenue from patient education and screening services and CRO services amounted to approximately RMB 14.3 million and RMB 3.7 million, accounting for 8.3% and 2.1% of total revenue respectively.

As of June 2022, the Group has developed and iterated multiple medical digital marketing platforms and products to provide customers with customized medical digital marketing solutions. This includes Giraffe Smart Medical Platform, Digital Patient Management Platform, E Conference, Giraffe Live, Deer Class, E Creation, E Insight and other products. As of June 30, 2022, the digital platform has 384,965 registered physician users, 46,518 online educational sessions with physicians and 25,687 online educational sessions for patients, and 4,855 live It was streamed, with 6,319 videos available and viewed by 1,086,328 visitors.

Meanwhile, Mediwelcome has continued its efforts to develop and expand its online healthcare platform to meet the growing needs of various stakeholders in the medical field, including hospitals, doctors, pharmaceutical companies, and medical device companies. rice field. The Group’s online healthcare platform not only provides doctors and patients with consistent and high-quality online medical service solutions, but also actively develops digital management products and services for out-of-hospital chronic disease patients. . As of June 30, 2022, the number of registered physician and patient users has reached 45,244 and 200,545, representing year-on-year increases of 69.9% and 321.2%, respectively. In addition, revenue from Internet hospital services increased by approximately 5.6% year-on-year to approximately RMB1.9, owing to an increase in the number of active patient users purchasing prescription drugs through the Group’s Internet hospital platform.

Continuously upgrade the digital marketing business and seize growth opportunities to create greater value

Going forward, Mediwelcome will continue to scale up its digital marketing business and leverage its internal and external strengths and resources to further focus on developing digital marketing customers in the healthcare market. At the same time, the Group will continue its efforts to build a digital platform with accurate access for physicians and patients, using a digital integrated marketing system in which both offline and online channels are synergistic. to provide customers with integrated digital and intelligent marketing solutions. Create a closed loop for the entire process of digital manipulation. The Group will continue to upgrade its online medical platform, explore the application of AI technology, and build a closed-loop business model from in-hospital to out-of-hospital. In addition, leveraging a favorable health policy environment and unique resources, Mediwelcome will focus on expanding its business in the fields of oncology and chronic kidney disease, as well as specialized medical and marketing services in the traditional cardiovascular and cerebrovascular fields. maintain revenue growth. Ill to increase customer coverage from domestic companies.

While maintaining the scale of our business in the existing dominant therapeutic area, the Group will actively promote innovation, capture opportunities arising from the rapid expansion of demand for medical digital marketing and online healthcare, and achieve steady growth. I will continue. The Group is actively generating profits under efficient operations, while continuously expanding and developing its business model and scale to create greater value for more customers, physicians and patients.